The deal has analysts puzzled, as the US maker of Tylenol has seen sales dip after the White House linked it to autism.
Kimberly-Clark to buy Tylenol maker Kenvue for $40bn
Related Posts
What challenge do ‘cockroach’ protests pose for India’s PM Modi?
Youth-led movement plans more demonstrations for next month.
Trump administration: Kennedy Center may be demolished if repairs not made
Department of Justice lawyers told a federal judge the venue ‘cannot survive’ without the US president’s help.